Weimei Health Technology (Beijing) Co., Ltd. has successfully concluded a Series A funding round worth hundreds of millions of yuan, led by Hongding Capital. The proceeds from this financing will primarily support the research and development of the "Singularity Medical Inquiry" large-scale medical model, algorithm enhancements, and the advancement of the national service network system. Weimei Health is dedicated to leveraging AI technology to address challenges such as resource scarcity, limited service scope, and inefficiencies within county-level primary healthcare. To date, the company has forged partnerships with nearly 3,000 medical institutions, over 2,000 of which are county-level or primary healthcare facilities.
Looking ahead, Weimei Health plans to intensify investments in large-scale medical model R&D, leveraging its proprietary large models to bolster primary healthcare service capabilities and cater to the evolving demands of primary medical diagnosis and service upgrades. Furthermore, the company has garnered multiple accolades and holds 67 patents in the realm of AI-driven healthcare. It is now accelerating the deployment and implementation of large-scale medical models in county-level primary healthcare, aiming to comprehensively elevate the standards of primary medical services.
